JF
ROIV icon

Jump Financial’s Roivant Sciences ROIV Stock Holding History

Jump Financial’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,592
Closed -$210K – 2156
2025
Q2 		$210K Buy
18,592
+3,622
+24% +$39.3K ﹤0.01% 1579
2025
Q1 		$151K Buy
14,970
+3,553
+31% +$38.4K ﹤0.01% 1468
2024
Q4 		$135K Buy
+11,417
New +$135K ﹤0.01% 1525
2023
Q4 		– Sell
-416,667
Closed -$4.87M – 2176
2023
Q3 		$4.87M Buy
+416,667
New +$4.71M 0.18% 114
2023
Q1 		– Sell
-166,204
Closed -$1.33M – 1985
2022
Q4 		$1.33M Buy
+166,204
New +$925K 0.07% 379
2022
Q2 		– Sell
-41,243
Closed -$203K – 1966
2022
Q1 		$203K Buy
+41,243
New +$272K 0.01% 1298

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Jump Financial's ROIV Position: Q3 2025 in Review

Jump Financial sold out of Roivant Sciences (ROIV) in Q3 2025, closing a stake of 18,592 shares — an estimated $210K sold.

Jump Financial first reported a position in ROIV in Q1 2022 and held it in 6 quarters. The position peaked at $4.87M in Q3 2023. 337 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • Jump Financial reported no remaining Roivant Sciences position as of Q3 2025 after selling out during the quarter.
  • Jump Financial sold 18,592 Roivant Sciences shares in Q3 2025, an estimated $210K.
  • Jump Financial first reported a position in Roivant Sciences in Q1 2022 and held it in 6 quarters.
  • Jump Financial's Roivant Sciences position peaked at $4.87M in Q3 2023.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Jump Financial's 13F filing for Q3 2025, filed 13 Nov 2025.